Xuelian Cui

699 total citations
17 papers, 489 citations indexed

About

Xuelian Cui is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuelian Cui has authored 17 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuelian Cui's work include Genomics, phytochemicals, and oxidative stress (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Genetic factors in colorectal cancer (2 papers). Xuelian Cui is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Genetic factors in colorectal cancer (2 papers). Xuelian Cui collaborates with scholars based in China, United States and Saudi Arabia. Xuelian Cui's co-authors include Zhenhua Lin, Shuangping Liu, Liyan Chen, Yan Zhang, Qunying Wu, Yang� Yang, Guang Jin, Junjie Piao, Guanghai Yan and Lianhua Li and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Xuelian Cui

17 papers receiving 483 citations

Peers

Countries citing papers authored by Xuelian Cui

Since Specialization

Citations

This map shows the geographic impact of Xuelian Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuelian Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuelian Cui more than expected).

Fields of papers citing papers by Xuelian Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuelian Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuelian Cui. The network helps show where Xuelian Cui may publish in the future.

Co-authorship network of co-authors of Xuelian Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xuelian Cui. A scholar is included among the top collaborators of Xuelian Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuelian Cui. Xuelian Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	RCC2 and CD24 cooperate to modulate prostate cancer progression through vimentin ubiquitination and β-catenin activation 2025 ·Journal of Clinical Investigation ·Xuelian Cui, Yicun Wang, Yong Zhang, Zhichao Liu, Haiyan Yu, Lizhong Wang, Jiangbing Zhou, Runhua Liu	1
2	Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer 2022 ·Oncogene ·Chao Wang, (unknown), Chao Zhang, Zhichao Liu, (unknown), Yicun Wang, Guangxin Zhang, Shuaibin Wang, Xuelian Cui, Yue Zhang, Sejong Bae, Jiangbing Zhou, Lizhong Wang, Runhua Liu	12
3	SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α 2021 ·Cellular Oncology ·Xuelian Cui, Yixuan Wang, (unknown), Shuhao Wang, Ying Cui, Xianglan Zhang, Zhenhua Lin, Junjie Piao	16
4	Abstract 778: CD24 mutant p53 contribute to racial disparities in prostate cancer 2021 ·Cancer Research ·Xuelian Cui, Shuaibin Wang, Lizhong Wang	1
5	Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin–AKT Signaling Pathway in Lung Cancer 2020 ·Molecular Cancer Research ·(unknown), Guangxin Zhang, Yue Zhang, Xuelian Cui, (unknown), Song Gao, (unknown), Ying Liu, (unknown), Wei‐Hsiung Yang, Lei S. Qi, Lizhong Wang, Runhua Liu	76
6	Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma 2018 ·Human Pathology ·Yixuan Wang, Junjie Piao, Qianrong Wang, Xuelian Cui, (unknown), Tiefeng Jin, Zhenhua Lin	17
7	Mortalin expression in pancreatic cancer and its clinical and prognostic significance 2017 ·Human Pathology ·Xuelian Cui, Zhenling Li, Junjie Piao, (unknown), Longshan Li, Zhenhua Lin, (unknown)	23
8	Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma 2017 ·Oncology Letters ·(unknown), (unknown), Jie Sun, Xuelian Cui, Yang Yang, Liyan Chen, Zhenhua Lin	17
9	[Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma]. 2016 ·PubMed ·Jienan Kong, (unknown), (unknown), (unknown), Xuelian Cui, Zhenhua Lin	5
10	Clinical implication of Tiam1 overexpression in the prognosis of patients with serous ovarian carcinoma 2016 ·Oncology Letters ·Huiwen Li, Xuelian Cui, (unknown), Yang Yang, Junjie Piao, Zhenhua Lin, Guanghai Yan, Danhua Shen	11
11	High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma 2015 ·BMC Cancer ·Xuelian Cui, Lianhua Li, Guanghai Yan, Kai Meng, Zhenhua Lin, (unknown), Guang Jin, Chunyu Li	68
12	Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer 2015 ·Experimental and Molecular Pathology ·(unknown), (unknown), Yunbo Chen, Shuangping Liu, Jingwei Xu, Xuelian Cui, Yan Zhang, Longzhen Piao	13
13	[Significance of NAD (P) H: quinone oxidoreductase 1 overexpression in prognostic evaluation of thyroid medullary carcinoma]. 2015 ·PubMed ·(unknown), Xuelian Cui, Yuan Zhang, Yang Yang, Long Shan Li, Zhenhua Lin, Liyan Chen	2
14	Clinical implications of high NQO1 expression in breast cancers 2014 ·Journal of Experimental & Clinical Cancer Research ·Yang� Yang, Yan Zhang, Qunying Wu, Xuelian Cui, Zhenhua Lin, Shuangping Liu, Liyan Chen	147
15	NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer 2014 ·Oncology Reports ·Xuelian Cui, Tiefeng Jin, Xiaoyan Wang, Guang Jin, (unknown), Lijuan Lin	33
16	Sineoculis homeobox homolog 1 protein is associated with breast cancer progression and survival outcome 2014 ·Experimental and Molecular Pathology ·(unknown), Minghua Cui, Jienan Kong, Xuelian Cui, Zhenhua Lin, (unknown), Shuangping Liu	13
17	High expression of DEK predicts poor prognosis of gastric adenocarcinoma 2014 ·Diagnostic Pathology ·Junjie Piao, (unknown), Shuangping Liu, (unknown), Xuelian Cui, (unknown), Zhenhua Lin	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact